Nutritional phases in Prader-Willi syndrome
- PMID: 21465655
- PMCID: PMC3285445
- DOI: 10.1002/ajmg.a.33951
Nutritional phases in Prader-Willi syndrome
Abstract
Prader-Willi syndrome (PWS) is a complex neurobehavioral condition which has been classically described as having two nutritional stages: poor feeding, frequently with failure to thrive (FTT) in infancy (Stage 1), followed by hyperphagia leading to obesity in later childhood (Stage 2). We have longitudinally followed the feeding behaviors of individuals with PWS and found a much more gradual and complex progression of the nutritional phases than the traditional two stages described in the literature. Therefore, this study characterizes the growth, metabolic, and laboratory changes associated with the various nutritional phases of PWS in a large cohort of subjects. We have identified a total of seven different nutritional phases, with five main phases and sub-phases in phases 1 and 2. Phase 0 occurs in utero, with decreased fetal movements and growth restriction compared to unaffected siblings. In phase 1 the infant is hypotonic and not obese, with sub-phase 1a characterized by difficulty feeding with or without FTT (ages birth-15 months; median age at completion: 9 months). This phase is followed by sub-phase 1b when the infant grows steadily along a growth curve and weight is increasing at a normal rate (median age of onset: 9 months; age quartiles 5-15 months). Phase 2 is associated with weight gain-in sub-phase 2a the weight increases without a significant change in appetite or caloric intake (median age of onset 2.08 years; age quartiles 20-31 months;), while in sub-phase 2b the weight gain is associated with a concomitant increased interest in food (median age of onset: 4.5 years; quartiles 3-5.25 years). Phase 3 is characterized by hyperphagia, typically accompanied by food-seeking and lack of satiety (median age of onset: 8 years; quartiles 5-13 years). Some adults progress to phase 4 which is when an individual who was previously in phase 3 no longer has an insatiable appetite and is able to feel full. Therefore, the progression of the nutritional phases in PWS is much more complex than previously recognized. Awareness of the various phases will aid researchers in unraveling the pathophysiology of each phase and provide a foundation for developing rational therapies. Counseling parents of newly diagnosed infants with PWS as to what to expect with regard to these nutritional phases may help prevent or slow the early-onset of obesity in this syndrome.
Copyright © 2011 Wiley-Liss, Inc.
Figures

Comment in
-
Energy homeostasis in Prader-Willi syndrome: how clinical research informs studies of animal models of genetic obesity: comment on "Nutritional phases in Prader-Willi syndrome," Miller et al., 2011. Am J Med Genet Part A, 155:1040-1049.Am J Med Genet A. 2012 Apr;158A(4):966-8. doi: 10.1002/ajmg.a.35249. Epub 2012 Mar 14. Am J Med Genet A. 2012. PMID: 22419655 No abstract available.
Similar articles
-
Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.Am J Med Genet A. 2015 Jan;167A(1):69-79. doi: 10.1002/ajmg.a.36810. Epub 2014 Oct 29. Am J Med Genet A. 2015. PMID: 25355237 Free PMC article.
-
Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader-Willi syndrome.Obes Sci Pract. 2023 Feb 17;9(4):383-394. doi: 10.1002/osp4.663. eCollection 2023 Aug. Obes Sci Pract. 2023. PMID: 37546289 Free PMC article.
-
Longitudinal Changes in Acylated versus Unacylated Ghrelin Levels May Be Involved in the Underlying Mechanisms of the Switch in Nutritional Phases in Prader-Willi Syndrome.Horm Res Paediatr. 2024;97(4):343-352. doi: 10.1159/000534560. Epub 2023 Oct 13. Horm Res Paediatr. 2024. PMID: 37839403 Free PMC article.
-
Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.Nutrients. 2022 May 6;14(9):1950. doi: 10.3390/nu14091950. Nutrients. 2022. PMID: 35565916 Free PMC article. Review.
-
Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.Obes Rev. 2020 May;21(5):e12992. doi: 10.1111/obr.12992. Epub 2019 Dec 30. Obes Rev. 2020. PMID: 31889409 Review.
Cited by
-
Growth hormone therapy for Prader-willi syndrome: challenges and solutions.Ther Clin Risk Manag. 2016 Jun 2;12:873-81. doi: 10.2147/TCRM.S70068. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27330297 Free PMC article. Review.
-
Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.Korean J Pediatr. 2012 Jul;55(7):224-31. doi: 10.3345/kjp.2012.55.7.224. Epub 2012 Jul 17. Korean J Pediatr. 2012. PMID: 22844316 Free PMC article.
-
Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.J Pediatr Endocrinol Metab. 2022 Dec 5;36(2):185-194. doi: 10.1515/jpem-2022-0468. Print 2023 Feb 23. J Pediatr Endocrinol Metab. 2022. PMID: 36458449 Free PMC article.
-
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1696-1708. doi: 10.1210/clinem/dgad015. J Clin Endocrinol Metab. 2023. PMID: 36633570 Free PMC article. Clinical Trial.
-
The Hyperphagia Questionnaire: Insights From a Multicentric Validation Study in Individuals With Prader Willi Syndrome.Front Pediatr. 2022 Feb 14;10:829486. doi: 10.3389/fped.2022.829486. eCollection 2022. Front Pediatr. 2022. PMID: 35237541 Free PMC article.
References
-
- Bizzarri C, Rigamonti AE, Luce A, Cappa M, Cella SG, Berini J, Sartorio A, Muller EE, Salvatoni A. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur J Endocrinol. 2010;162:499–505. - PubMed
-
- Burman P, Ritzén EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH. Endocr Rev. 2001;22:787–799. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases